Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

193 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Characteristics and prognosis of patients with COVID-19 and hematological diseases in Japan: a cross-sectional study.
Minakata D, Uchida T, Nakano A, Takase K, Tsukada N, Kosugi H, Kawata E, Nakane T, Takahashi H, Endo T, Nishiwaki S, Fujiwara H, Saito AM, Saito TI, Akashi K, Matsumura I, Mitani K. Minakata D, et al. Among authors: nishiwaki s. Int J Hematol. 2024 Feb;119(2):183-195. doi: 10.1007/s12185-023-03685-w. Epub 2024 Jan 3. Int J Hematol. 2024. PMID: 38172385 Free PMC article.
Minimal residual disease (MRD) positivity at allogeneic hematopoietic cell transplantation, not the quantity of MRD, is a risk factor for relapse of Philadelphia chromosome-positive acute lymphoblastic leukemia.
Akahoshi Y, Arai Y, Nishiwaki S, Mizuta S, Marumo A, Uchida N, Kanda Y, Sakai H, Takada S, Fukuda T, Fujisawa S, Ashida T, Tanaka J, Atsuta Y, Kako S. Akahoshi Y, et al. Among authors: nishiwaki s. Int J Hematol. 2021 Jun;113(6):832-839. doi: 10.1007/s12185-021-03094-x. Epub 2021 Feb 11. Int J Hematol. 2021. PMID: 33570732 Clinical Trial.
Optimal treatment for Philadelphia-negative acute lymphoblastic leukemia in first remission in the era of high-intensity chemotherapy.
Kako S, Hayakawa F, Imai K, Tanaka J, Mizuta S, Nishiwaki S, Kanamori H, Mukae J, Ozawa Y, Kondo T, Fukuda T, Ichinohe T, Ota S, Tanaka Y, Murayama T, Kurahashi S, Sakura T, Usui N, Ohtake S, Kiyoi H, Matsumura I, Miyazaki Y, Atsuta Y. Kako S, et al. Among authors: nishiwaki s. Int J Hematol. 2021 Nov;114(5):608-619. doi: 10.1007/s12185-021-03198-4. Epub 2021 Jul 30. Int J Hematol. 2021. PMID: 34328634
High-risk Combinations of Additional Chromosomal Abnormalities in Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia: JALSG Ph+ALL TKI-SCT Study.
Nishiwaki S, Sugiura I, Fujisawa S, Hatta Y, Atsuta Y, Doki N, Kurahashi S, Ueda Y, Dobashi N, Maeda T, Taniguchi Y, Tanaka M, Kako S, Ichinohe T, Fukuda T, Ohtake S, Ishikawa Y, Kiyoi H, Matsumura I, Miyazaki Y. Nishiwaki S, et al. Hemasphere. 2023 Jun 8;7(6):e899. doi: 10.1097/HS9.0000000000000899. eCollection 2023 Jun. Hemasphere. 2023. PMID: 37475881 Free PMC article. No abstract available.
Utility of allogeneic stem cell transplantation for adult Ph+ALL with complete molecular remission.
Nishiwaki S, Sugiura I, Fujisawa S, Hatta Y, Atsuta Y, Doki N, Kurahashi S, Ueda Y, Dobashi N, Maeda T, Matsumura I, Tanaka M, Kako S, Ichinohe T, Fukuda T, Ohtake S, Ishikawa Y, Miyazaki Y, Kiyoi H; Japan Adult Leukemia Study Group. Nishiwaki S, et al. Am J Hematol. 2024 May;99(5):806-815. doi: 10.1002/ajh.27237. Epub 2024 Feb 5. Am J Hematol. 2024. PMID: 38314662
Outcome of allogeneic bone marrow transplantation from unrelated donors for adult Philadelphia chromosome-negative acute lymphocytic leukemia in first complete-remission.
Nishiwaki S, Terakura S, Yasuda T, Imahashi N, Sao H, Iida H, Kamiya Y, Niimi K, Morishita Y, Kohno A, Yokozawa T, Ohashi H, Sawa M, Kodera Y, Miyamura K. Nishiwaki S, et al. Int J Hematol. 2010 Apr;91(3):419-25. doi: 10.1007/s12185-010-0509-9. Epub 2010 Feb 10. Int J Hematol. 2010. PMID: 20146028
Dexamethasone palmitate successfully attenuates hemophagocytic syndrome after allogeneic stem cell transplantation: macrophage-targeted steroid therapy.
Nishiwaki S, Nakayama T, Murata M, Nishida T, Sugimoto K, Saito S, Kato T, Mizuno H, Imahashi N, Seto A, Ozawa Y, Goto T, Koyama D, Yokohata E, Kubota N, Kamoshita S, Miyamura K, Matsumoto K, Ito M, Naoe T. Nishiwaki S, et al. Int J Hematol. 2012 Apr;95(4):428-33. doi: 10.1007/s12185-012-1023-z. Epub 2012 Feb 15. Int J Hematol. 2012. PMID: 22351164
Reduced-intensity vs myeloablative conditioning allogeneic hematopoietic SCT for patients aged over 45 years with ALL in remission: a study from the Adult ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT).
Tanaka J, Kanamori H, Nishiwaki S, Ohashi K, Taniguchi S, Eto T, Nakamae H, Minagawa K, Miyamura K, Sakamaki H, Morishima Y, Kato K, Suzuki R, Nishimoto N, Oba K, Masauzi N. Tanaka J, et al. Among authors: nishiwaki s. Bone Marrow Transplant. 2013 Nov;48(11):1389-94. doi: 10.1038/bmt.2013.68. Epub 2013 May 13. Bone Marrow Transplant. 2013. PMID: 23665820
193 results